Home > Healthcare > Medical Devices > Therapeutic Devices > Extracorporeal Membrane Oxygenation Market
Extracorporeal membrane oxygenation market from veno-arterial (VA) segment held more than USD 220 million in 2022 and is anticipated to reach over USD 290 million by 2032. This is due to its widespread application in treating patients suffering from cardiac arrest, pulmonary embolism, pulmonary hypertension, and other diseases. Therefore, growing applications and product adoption will stimulate the demand for veno-arterial extracorporeal membrane oxygenation.
Respiratory segment dominated the ECMO market accounting for more than 65% business share in 2022. The risk of respiratory failure among patients suffering from various respiratory disorders is a major contributor to segment growth. Additionally, expanding geriatric population base prone to suffer from respiratory illnesses is said to stimulate the market landscape.
Extracorporeal membrane oxygenation market from paediatric segment was valued at over USD 100 million in 2022 is anticipated to reach more than 135 million by 2032. The device is used to treat diverse types of diseases in children, including meconium aspiration syndrome, pneumonia, congenital diaphragmatic hernia (CDH), and respiratory distress syndrome (RDS).
North America extracorporeal membrane oxygenation market accounted for more than 59% in 2022. This is driven by well-developed healthcare infrastructure, rising prevalence of pulmonary diseases and expanding geriatric population base. The regional growth is further enhanced by the presence of a highly developed co-payment and insurance system along with presence of established industry players in the region.